{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:39:05Z","timestamp":1779118745853,"version":"3.51.4"},"reference-count":109,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2015.00168","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T06:10:39Z","timestamp":1446703839000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders"],"prefix":"10.3389","volume":"6","author":[{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jb\/mvq121","article-title":"Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease","volume":"149","author":"Itoh","year":"2011","journal-title":"J Biochem"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1093\/carcin\/bgt254","article-title":"Fibroblast growth factor receptors, developmental corruption and malignant disease","volume":"34","author":"Kelleher","year":"2013","journal-title":"Carcinogenesis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","article-title":"Evolution of the Fgf and Fgfr gene families","volume":"20","author":"Itoh","year":"2004","journal-title":"Trends Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"Nishimura","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.1073\/pnas.0701600104","article-title":"BetaKlotho is required for metabolic activity of fibroblast growth factor 21","volume":"104","author":"Ogawa","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.21357","article-title":"FGF-21\/FGF-21 receptor interaction and activation is determined by betaKlotho","volume":"215","author":"Kharitonenkov","year":"2008","journal-title":"J Cell Physiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1210\/me.2007-0313","article-title":"BetaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c","volume":"22","author":"Suzuki","year":"2008","journal-title":"Mol Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00441-010-1024-2","article-title":"Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease","volume":"342","author":"Itoh","year":"2010","journal-title":"Cell Tissue Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.bbadis.2011.04.002","article-title":"Hormone-like fibroblast growth factors and metabolic regulation","volume":"1812","author":"Long","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1210\/en.2009-0532","article-title":"Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis","volume":"150","author":"Badman","year":"2009","journal-title":"Endocrinology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/ncomms3019","article-title":"Fibroblast growth factor 21 protects against cardiac hypertrophy in mice","volume":"4","author":"Planavila","year":"2013","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2265.2008.03502.x","article-title":"Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity","volume":"71","author":"Mraz","year":"2009","journal-title":"Clin Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.2337\/dc09-0684","article-title":"Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance","volume":"32","author":"Chavez","year":"2009","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"E54","DOI":"10.1210\/jc.2011-1930","article-title":"Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes","volume":"97","author":"Xiao","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1210\/jc.2008-2331","article-title":"Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects","volume":"94","author":"Li","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1365-2362.2010.02338.x","article-title":"Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease","volume":"40","author":"Yilmaz","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","article-title":"Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride","volume":"53","author":"Li","year":"2010","journal-title":"J Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e15534","DOI":"10.1371\/journal.pone.0015534","article-title":"Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile","volume":"5","author":"Lin","year":"2010","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1475-2840-12-124","article-title":"Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease","volume":"12","author":"Shen","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1161\/ATVBAHA.113.301599","article-title":"Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors","volume":"33","author":"Chow","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/cen.12380","article-title":"Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction","volume":"80","author":"Hindricks","year":"2014","journal-title":"Clin Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e18398","DOI":"10.1371\/journal.pone.0018398","article-title":"Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"E98","DOI":"10.1210\/jc.2012-3107","article-title":"Mild cold exposure modulates fibroblast growth factor 21 (FGF21) diurnal rhythm in humans: relationship between FGF21 levels, lipolysis, and cold-induced thermogenesis","volume":"98","author":"Lee","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"10275","DOI":"10.1038\/srep10275","article-title":"Serum FGF21 levels are associated with brown adipose tissue activity in humans","volume":"5","author":"Hanssen","year":"2015","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"254S","DOI":"10.3945\/ajcn.2009.28449B","article-title":"Fibroblast growth factor 21: from pharmacology to physiology","volume":"91","author":"Kliewer","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tem.2010.11.003","article-title":"FGF21 reloaded: challenges of a rapidly growing field","volume":"22","author":"Kharitonenkov","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1101\/gad.184788.111","article-title":"Endocrine fibroblast growth factors 15\/19 and 21: from feast to famine","volume":"26","author":"Potthoff","year":"2012","journal-title":"Genes Dev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cmet.2012.11.001","article-title":"Circulating fibroblast growth factors as metabolic regulators\u2009\u2013\u2009a critical appraisal","volume":"16","author":"Angelin","year":"2012","journal-title":"Cell Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.molmet.2013.12.003","article-title":"Inventing new medicines: the FGF21 story","volume":"3","author":"Kharitonenkov","year":"2014","journal-title":"Mol Metab"},{"key":"B32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.drudis.2013.10.021","article-title":"Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome","volume":"19","author":"Zhang","year":"2014","journal-title":"Drug Discov Today"},{"key":"B33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tem.2014.03.001","article-title":"FGF21-based pharmacotherapy\u2009\u2013\u2009potential utility for metabolic disorders","volume":"25","author":"Gimeno","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tem.2014.10.002","article-title":"Tissue-specific actions of the metabolic hormones FGF15\/19 and FGF21","volume":"26","author":"Owen","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cmet.2012.08.002","article-title":"BetaKlotho is required for fibroblast growth factor 21 effects on growth and metabolism","volume":"16","author":"Ding","year":"2012","journal-title":"Cell Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e00065","DOI":"10.7554\/eLife.00065","article-title":"The starvation hormone, fibroblast growth factor-21, extends lifespan in mice","volume":"1","author":"Zhang","year":"2012","journal-title":"Elife"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1210\/en.2009-0221","article-title":"Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity","volume":"150","author":"Berglund","year":"2009","journal-title":"Endocrinology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"E1105","DOI":"10.1152\/ajpendo.00348.2009","article-title":"Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models\u2009\u2013\u2009association with liver and adipose tissue effects","volume":"297","author":"Xu","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21","volume":"148","author":"Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.febslet.2008.04.038","article-title":"FGF21 attenuates lipolysis in human adipocytes\u2009\u2013\u2009a possible link to improved insulin sensitivity","volume":"582","author":"Arner","year":"2008","journal-title":"FEBS Lett"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1016\/j.febslet.2009.09.012","article-title":"Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob\/ob mice","volume":"583","author":"Li","year":"2009","journal-title":"FEBS Lett"},{"key":"B45","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metab"},{"key":"B46","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","article-title":"Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice","volume":"17","author":"Lin","year":"2013","journal-title":"Cell Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","article-title":"Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy","volume":"12","author":"Shimomura","year":"1998","journal-title":"Genes Dev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e40164","DOI":"10.1371\/journal.pone.0040164","article-title":"FGF21 promotes metabolic homeostasis via white adipose and leptin in mice","volume":"7","author":"Veniant","year":"2012","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"162ra153","DOI":"10.1126\/scitranslmed.3004690","article-title":"Treating diabetes and obesity with an FGF21-mimetic antibody activating the betaKlotho\/FGFR1c receptor complex","volume":"4","author":"Foltz","year":"2012","journal-title":"Sci Transl Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molmet.2012.08.007","article-title":"The breadth of FGF21\u2019s metabolic actions are governed by FGFR1 in adipose tissue","volume":"2","author":"Adams","year":"2013","journal-title":"Mol Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"26687","DOI":"10.1074\/jbc.M704165200","article-title":"Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21","volume":"282","author":"Kurosu","year":"2007","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1210\/en.2011-0281","article-title":"Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo","volume":"152","author":"Fisher","year":"2011","journal-title":"Endocrinology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1101\/gad.177857.111","article-title":"FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis","volume":"26","author":"Fisher","year":"2012","journal-title":"Genes Dev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2119\/molmed.2011.00075","article-title":"Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21","volume":"17","author":"Chartoumpekis","year":"2011","journal-title":"Mol Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"12983","DOI":"10.1074\/jbc.M110.215889","article-title":"Thermogenic activation induces FGF21 expression and release in brown adipose tissue","volume":"286","author":"Hondares","year":"2011","journal-title":"J Biol Chem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.celrep.2015.04.046","article-title":"Discrete aspects of FGF21 in vivo pharmacology do not require UCP1","volume":"11","author":"Samms","year":"2015","journal-title":"Cell Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cmet.2015.04.019","article-title":"Pharmacologic effects of FGF21 are independent of the \u201cbrowning\u201d of white adipose tissue","volume":"21","author":"Veniant","year":"2015","journal-title":"Cell Metab"},{"key":"B58","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab"},{"key":"B59","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bbrc.2007.06.068","article-title":"PPARalpha is a key regulator of hepatic FGF21","volume":"360","author":"Lundasen","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1517\/14728222.2014.944898","article-title":"The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target","volume":"18","author":"Liu","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1053\/j.gastro.2014.07.044","article-title":"Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets","volume":"147","author":"Fisher","year":"2014","journal-title":"Gastroenterology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.metabol.2011.10.012","article-title":"Association between serum fibroblast growth factor 21 and diabetic nephropathy","volume":"61","author":"Jian","year":"2012","journal-title":"Metabolism"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1210\/en.2012-2276","article-title":"Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db\/db mice","volume":"154","author":"Kim","year":"2013","journal-title":"Endocrinology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.diabres.2012.01.004","article-title":"Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques","volume":"96","author":"An","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"B66","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12933-015-0229-9","article-title":"Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes","volume":"14","author":"Xiao","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cvr\/cvu263","article-title":"Fibroblast growth factor 21 protects the heart from oxidative stress","volume":"106","author":"Planavila","year":"2015","journal-title":"Cardiovasc Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1194\/jlr.M044784","article-title":"Fibroblast growth factor 21 is induced upon cardiac stress and alters cardiac lipid homeostasis","volume":"55","author":"Brahma","year":"2014","journal-title":"J Lipid Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.2337\/db13-0645","article-title":"High glucose represses beta-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor gamma signaling","volume":"62","author":"So","year":"2013","journal-title":"Diabetes"},{"key":"B70","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e65763","DOI":"10.1371\/journal.pone.0065763","article-title":"LY2405319, an engineered FGF21 variant, improves the metabolic status of diabetic monkeys","volume":"8","author":"Adams","year":"2013","journal-title":"PLoS One"},{"key":"B72","first-page":"897","article-title":"[Optimization and characterization of a novel FGF21 mutant]","volume":"47","author":"Ye","year":"2012","journal-title":"Yao Xue Xue Bao"},{"key":"B73","doi-asserted-by":"publisher","first-page":"33304","DOI":"10.1074\/jbc.M803319200","article-title":"C-terminal tail of FGF19 determines its specificity toward klotho co-receptors","volume":"283","author":"Wu","year":"2008","journal-title":"J Biol Chem"},{"key":"B74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.febslet.2008.11.023","article-title":"FGF21 N- and C-termini play different roles in receptor interaction and activation","volume":"583","author":"Yie","year":"2009","journal-title":"FEBS Lett"},{"key":"B75","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/jcp.21675","article-title":"Different roles of N- and C- termini in the functional activity of FGF21","volume":"219","author":"Micanovic","year":"2009","journal-title":"J Cell Physiol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e49345","DOI":"10.1371\/journal.pone.0049345","article-title":"Rationale-based engineering of a potent long-acting FGF21 analog for the treatment of type 2 diabetes","volume":"7","author":"Hecht","year":"2012","journal-title":"PLoS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1128\/MCB.06603-11","article-title":"Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands","volume":"32","author":"Goetz","year":"2012","journal-title":"Mol Cell Biol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40259-013-0013-x","article-title":"A novel approach to improve the function of FGF21","volume":"27","author":"Smith","year":"2013","journal-title":"BioDrugs"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e20669","DOI":"10.1371\/journal.pone.0020669","article-title":"A better anti-diabetic recombinant human fibroblast growth factor 21 (rhFGF21) modified with polyethylene glycol","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS One"},{"key":"B80","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1021\/bc300603k","article-title":"Polyethylene glycol modified FGF21 engineered to maximize potency and minimize vacuole formation","volume":"24","author":"Xu","year":"2013","journal-title":"Bioconjug Chem"},{"key":"B81","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2337\/db11-0838","article-title":"FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents","volume":"61","author":"Mu","year":"2012","journal-title":"Diabetes"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1021\/ac303203y","article-title":"Differential enzyme-linked immunosorbent assay and ligand-binding mass spectrometry for analysis of biotransformation of protein therapeutics: application to various FGF21 modalities","volume":"85","author":"Hager","year":"2013","journal-title":"Anal Chem"},{"key":"B83","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1210\/en.2012-1211","article-title":"Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys","volume":"153","author":"Veniant","year":"2012","journal-title":"Endocrinology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1124\/jpet.113.204420","article-title":"Development of a novel long-acting antidiabetic FGF21 mimetic by targeted conjugation to a scaffold antibody","volume":"346","author":"Huang","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"B85","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature13540","article-title":"Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer","volume":"513","author":"Suh","year":"2014","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4614-0887-1_13","article-title":"Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities","volume":"728","author":"Wu","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1074\/jbc.M109.068783","article-title":"FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation","volume":"285","author":"Wu","year":"2010","journal-title":"J Biol Chem"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e17868","DOI":"10.1371\/journal.pone.0017868","article-title":"FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e36713","DOI":"10.1371\/journal.pone.0036713","article-title":"Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models","volume":"7","author":"French","year":"2012","journal-title":"PLoS One"},{"key":"B90","doi-asserted-by":"publisher","first-page":"14158","DOI":"10.1073\/pnas.1009427107","article-title":"Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19)","volume":"107","author":"Wu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e33603","DOI":"10.1371\/journal.pone.0033603","article-title":"Characterization of a FGF19 variant with altered receptor specificity revealed a central role for FGFR1c in the regulation of glucose metabolism","volume":"7","author":"Ge","year":"2012","journal-title":"PLoS One"},{"key":"B92","doi-asserted-by":"publisher","first-page":"247ra100","DOI":"10.1126\/scitranslmed.3009098","article-title":"A nontumorigenic variant of FGF19 treats cholestatic liver diseases","volume":"6","author":"Luo","year":"2014","journal-title":"Sci Transl Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature10998","article-title":"A PPARgamma-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis","volume":"485","author":"Jonker","year":"2012","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jmb.2012.02.027","article-title":"A unique FGF23 with the ability to activate FGFR signaling through both alphaKlotho and betaKlotho","volume":"418","author":"Wu","year":"2012","journal-title":"J Mol Biol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"29134","DOI":"10.1074\/jbc.M112.342980","article-title":"Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor","volume":"287","author":"Goetz","year":"2012","journal-title":"J Biol Chem"},{"key":"B96","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"key":"B98","doi-asserted-by":"publisher","first-page":"113ra126","DOI":"10.1126\/scitranslmed.3002669","article-title":"Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1","volume":"3","author":"Wu","year":"2011","journal-title":"Sci Transl Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e112109","DOI":"10.1371\/journal.pone.0112109","article-title":"Monoclonal antibody targeting of fibroblast growth factor receptor 1c ameliorates obesity and glucose intolerance via central mechanisms","volume":"9","author":"Lelliott","year":"2014","journal-title":"PLoS One"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e57322","DOI":"10.1371\/journal.pone.0057322","article-title":"Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e61432","DOI":"10.1371\/journal.pone.0061432","article-title":"FGF21 can be mimicked in vitro and in vivo by a novel anti-FGFR1c\/beta-klotho bispecific protein","volume":"8","author":"Smith","year":"2013","journal-title":"PLoS One"},{"key":"B102","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ebiom.2015.05.028","article-title":"Sustained brown fat stimulation and insulin sensitization by a humanized bispecific antibody agonist for fibroblast growth factor receptor 1\/\u03b2Klotho complex","volume":"2","author":"Kolumam","year":"2015","journal-title":"EBioMedicine"},{"key":"B103","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cmet.2008.05.006","article-title":"Inhibition of growth hormone signaling by the fasting-induced hormone FGF21","volume":"8","author":"Inagaki","year":"2008","journal-title":"Cell Metab"},{"key":"B104","doi-asserted-by":"publisher","first-page":"26060","DOI":"10.1074\/jbc.M112.343707","article-title":"Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate","volume":"287","author":"Wu","year":"2012","journal-title":"J Biol Chem"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1073\/pnas.1200797109","article-title":"Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma","volume":"109","author":"Wei","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3249","article-title":"FGF21 regulates metabolism and circadian behavior by acting on the nervous system","volume":"19","author":"Bookout","year":"2013","journal-title":"Nat Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones","volume":"148","author":"Dutchak","year":"2012","journal-title":"Cell"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/nm.3250","article-title":"FGF21 contributes to neuroendocrine control of female reproduction","volume":"19","author":"Owen","year":"2013","journal-title":"Nat Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejphar.2013.06.023","article-title":"Pegylated Fgf21 rapidly normalizes insulin-stimulated glucose utilization in diet-induced insulin resistant mice","volume":"715","author":"Camacho","year":"2013","journal-title":"Eur J Pharmacol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"deposited":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T20:59:16Z","timestamp":1449003556000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fendo.2015.00168\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":109,"URL":"https:\/\/doi.org\/10.3389\/fendo.2015.00168","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]}}}